Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bilger

Showing results (371-380 of 405) with videos related to

Pageof 41
Sort By:
Bone Marrow Transplantation|June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMTJ R Passweg, M Labopin, J Cornelissen, et al.
Therapeutic Advances in Medical Oncology|June 13, 2022
Paclitaxel-bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric studyGeoffroy Bilger, Anne-Claire Toffart, Marie Darrason, et al.
Blood|August 30, 2003
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumorsDidier Blaise, Jacques Olivier Bay, Catherine Faucher, et al.
Haematologica|January 19, 2010
Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie CellulaireAlice Garnier, Marie Robin, Fabrice Larosa, et al.
JNCI Cancer Spectrum|February 19, 2021
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer PatientsClémence Basse, Sarah Diakite, Vincent Servois, et al.
Journal of Geriatric Oncology|June 28, 2015
Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective studyE Hermet, A Cabrespine, R Guièze, et al.
Annals of Hematology|June 22, 2020
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TCAmandine Le Bourgeois, Myriam Labopin, Ambroise Marçais, et al.
Haematologica|March 30, 2013
Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin's lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Ambroise Marcais, Raphael Porcher, Marie Robin, et al.
Journal of Viral Hepatitis|February 12, 2019
Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohortRamazan Idilman, Mehmet Demir, Murat Aladag, et al.
Rheumatology International|July 2, 2025
Transient elastography measurements of the liver and transplanted kidney in patients with AA amyloidosis: a cross-sectional comparative studyMurat Bektaş, Bilger Çavuş, Besim Fazıl Ağargün, et al.
Pageof 41

Showing results (371-380 of 405) with videos related to

Sort By:
Pageof 41
Bone Marrow Transplantation|June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMTJ R Passweg, M Labopin, J Cornelissen, et al.
Therapeutic Advances in Medical Oncology|June 13, 2022
Paclitaxel-bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric studyGeoffroy Bilger, Anne-Claire Toffart, Marie Darrason, et al.
Blood|August 30, 2003
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumorsDidier Blaise, Jacques Olivier Bay, Catherine Faucher, et al.
Haematologica|January 19, 2010
Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie CellulaireAlice Garnier, Marie Robin, Fabrice Larosa, et al.
JNCI Cancer Spectrum|February 19, 2021
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer PatientsClémence Basse, Sarah Diakite, Vincent Servois, et al.
Journal of Geriatric Oncology|June 28, 2015
Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective studyE Hermet, A Cabrespine, R Guièze, et al.
Annals of Hematology|June 22, 2020
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TCAmandine Le Bourgeois, Myriam Labopin, Ambroise Marçais, et al.
Haematologica|March 30, 2013
Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin's lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Ambroise Marcais, Raphael Porcher, Marie Robin, et al.
Journal of Viral Hepatitis|February 12, 2019
Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohortRamazan Idilman, Mehmet Demir, Murat Aladag, et al.
Rheumatology International|July 2, 2025
Transient elastography measurements of the liver and transplanted kidney in patients with AA amyloidosis: a cross-sectional comparative studyMurat Bektaş, Bilger Çavuş, Besim Fazıl Ağargün, et al.
Pageof 41